ENFN vs. VRNS, CVLT, CWAN, ZI, PWSC, WK, BLKB, BOX, FRSH, and ACIW
Should you be buying Enfusion stock or one of its competitors? The main competitors of Enfusion include Varonis Systems (VRNS), Commvault Systems (CVLT), Clearwater Analytics (CWAN), ZoomInfo Technologies (ZI), PowerSchool (PWSC), Workiva (WK), Blackbaud (BLKB), BOX (BOX), Freshworks (FRSH), and ACI Worldwide (ACIW). These companies are all part of the "prepackaged software" industry.
Varonis Systems (NASDAQ:VRNS) and Enfusion (NYSE:ENFN) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, community ranking, dividends, media sentiment, institutional ownership and valuation.
Varonis Systems has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.
Varonis Systems currently has a consensus price target of $49.06, suggesting a potential upside of 14.21%. Enfusion has a consensus price target of $9.33, suggesting a potential downside of 0.81%. Given Enfusion's stronger consensus rating and higher probable upside, research analysts plainly believe Varonis Systems is more favorable than Enfusion.
95.7% of Varonis Systems shares are held by institutional investors. Comparatively, 81.1% of Enfusion shares are held by institutional investors. 2.6% of Varonis Systems shares are held by company insiders. Comparatively, 36.4% of Enfusion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Varonis Systems had 1 more articles in the media than Enfusion. MarketBeat recorded 6 mentions for Varonis Systems and 5 mentions for Enfusion. Enfusion's average media sentiment score of 0.51 beat Varonis Systems' score of 0.50 indicating that Varonis Systems is being referred to more favorably in the media.
Enfusion has a net margin of 1.40% compared to Enfusion's net margin of -20.38%. Varonis Systems' return on equity of 6.60% beat Enfusion's return on equity.
Enfusion has lower revenue, but higher earnings than Varonis Systems. Varonis Systems is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.
Varonis Systems received 857 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 73.83% of users gave Varonis Systems an outperform vote while only 18.75% of users gave Enfusion an outperform vote.
Summary
Varonis Systems beats Enfusion on 10 of the 18 factors compared between the two stocks.
Get Enfusion News Delivered to You Automatically
Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ENFN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Enfusion Competitors List
Related Companies and Tools
